result
invas
devic
surgic
procedur
may
associ
shift
colon
infect
complex
interact
occur
throughout
bodi
commens
organ
barrier
colon
research
skin
gastrointestin
tract
microbiom
shed
light
interact
skin
protect
barrier
larg
number
colon
bacteria
skin
microbiom
inhabit
bacteria
fungi
virus
archaea
mite
howev
research
focus
bacteria
presenc
variou
microb
may
influenc
diseas
evidenc
shift
staphylococcu
epidermidi
cultur
healthi
skin
young
children
propionibacterium
acn
teenag
acn
children
atop
dermat
propens
infect
staphylococcu
aureu
loss
skin
integr
wound
burn
inflamm
invas
devic
allow
pathogen
enter
balanc
host
flora
also
import
gut
influenc
antibiot
usag
diarrheal
diseas
critic
ill
gut
provid
essenti
immun
respons
maintain
health
normal
flora
stimul
prolifer
epitheli
cell
small
larg
intestin
particip
develop
compet
gutassoci
immun
respons
well
provid
physic
barrier
function
pathogen
invas
colon
resist
inflammatori
bowel
diseas
one
exampl
alter
gut
flora
associ
diseas
state
secretori
antibodi
system
import
defens
mucos
infect
specif
secretori
immunoglobulin
iga
transport
secretori
epithelia
mucos
surfac
inhibit
pathogen
colon
microorgan
entrap
mucu
promot
clearanc
entrap
microb
via
peristalsi
mucociliari
movement
iga
also
play
role
mucos
protect
gut
bind
mucou
layer
separ
commens
bacteria
apic
surfac
intestin
epitheli
cell
patient
admit
hospit
bring
normal
flora
may
differ
previous
healthi
child
technologydepend
child
resid
longterm
care
facil
colon
children
organ
specif
individu
clinic
condit
pseudomona
aeruginosa
tracheostomyand
ventilatordepend
child
multidrugresist
enterobacteriacea
gi
tract
neurolog
impair
adolesc
neurogen
bladder
histori
frequent
urinari
tract
infect
may
lead
infect
pathogen
resid
organ
may
transfer
environ
acquir
directli
patient
transmit
indirectli
hcw
hand
highrisk
popul
acquisit
multidrugresist
organ
includ
critic
ill
immunocompromis
hospit
long
period
time
either
acut
care
longterm
care
set
addit
risk
factor
includ
prolong
use
antibiot
contact
colon
patient
colonizedcontamin
hand
hcw
colon
organ
may
produc
invas
infect
whether
colon
acquir
hospit
commun
colon
methicillinresist
staphylococcu
aureu
mrsa
risk
factor
subsequ
invas
mrsa
infect
studi
related
colon
strain
aureu
associ
invas
diseas
adult
found
aureu
blood
isol
ident
colon
patient
anterior
nare
genotyp
aureu
strain
surgic
site
infect
also
note
ident
colon
strain
surgic
patient
hospit
environ
repres
reservoir
organ
mrsa
vancomycinresist
enterococcu
vre
multidrugresist
gramneg
pathogen
well
clostridium
difficil
notabl
drugresist
organ
found
surfac
acut
care
hospit
set
found
outpati
set
transmiss
patient
environ
may
occur
directli
contamin
fomit
indirectli
fomit
hcw
hand
indirectli
patient
patient
hcw
hand
c
difficil
may
spread
indirect
fashion
exampl
organ
may
first
identifi
stool
hospit
patient
later
found
contamin
hospit
room
content
spread
hcw
hand
hospit
environ
hospit
surfac
may
serv
reservoir
vehicl
transmiss
pathogen
specif
pathogen
mrsa
pseudomona
aeruginosa
acinetobact
c
difficil
contamin
hospit
surfac
abil
surviv
environ
amount
hospit
surfac
contamin
vari
depend
bodi
site
infectioncolon
patient
type
clean
practic
vre
commonli
associ
environment
contamin
especi
presenc
diarrhea
studi
icu
patient
rate
environment
contamin
higher
patient
one
bodi
site
posit
vre
c
difficil
often
identifi
room
colon
infect
patient
prove
difficult
erad
due
resili
spore
frequenc
posit
environment
cultur
c
difficil
high
one
studi
environment
cultur
room
occupi
asymptomat
patient
posit
cultur
c
difficil
cultur
room
occupi
patient
c
difficileassoci
diarrhea
p
environment
isol
character
studi
immunoblot
type
ident
patient
outbreak
investig
adult
longterm
care
facil
c
difficil
skin
isol
asymptomat
patient
environment
surfac
match
sourc
patient
isol
case
respect
c
difficil
also
recov
physician
nurs
work
area
given
potenti
hospit
surfac
contamin
pathogen
stand
reason
hand
even
glove
hcw
becom
contamin
well
contamin
hand
hcw
occur
direct
patient
care
contact
contamin
surfac
posit
environment
cultur
found
risk
factor
develop
handglov
contamin
surprisingli
level
hand
contamin
shown
correl
level
environment
contamin
prior
room
occup
infect
healthcareassoci
hca
pathogen
may
provid
sourc
exposur
patient
admiss
room
prior
occup
infect
colon
mrsa
vre
acinetobact
c
difficil
risk
factor
subsequ
colon
infect
organ
special
termin
clean
patient
discharg
room
previous
occupi
patient
c
difficil
infect
includ
use
hydrogen
peroxid
vapor
implement
reduc
rate
subsequ
infect
procedur
led
reduc
rate
infect
patient
subsequ
admit
room
prior
room
occup
infect
colon
c
difficil
sinc
colon
may
lead
infect
two
basic
strategi
horizont
vertic
employ
reduc
hai
horizont
strategi
seek
broadli
reduc
burden
common
healthcareassoci
pathogen
includ
aureu
enterococcu
gramneg
bacteria
candida
intervent
hand
hygien
environment
clean
vertic
strategi
target
specif
pathogen
known
caus
hai
util
activ
surveil
test
well
direct
approach
decreas
colon
prevent
transmiss
subsequ
infect
gener
horizont
prevent
strategi
approach
elsewher
text
includ
hand
hygien
contact
precaut
isol
ppe
use
see
chap
principl
infect
control
strategi
appli
patient
known
risk
pathogen
colon
view
vertic
approach
fall
three
broad
categori
activ
surveil
test
ast
pathogenspecif
isol
decolon
screen
activ
surveil
test
ast
involv
detect
colon
patient
use
cultur
molecular
method
typic
focus
highrisk
pathogen
includ
aureu
mrsa
enterococcu
vre
c
difficil
transmit
persontoperson
colon
infect
patient
principl
strategi
challeng
controversi
ast
discuss
optim
sampl
ast
vari
pathogen
specimen
mrsa
test
frequent
obtain
nare
howev
aureu
also
colon
skin
perineum
pharynx
gi
tract
vagina
axilla
addit
site
screen
may
indic
depend
clinic
scenario
potenti
consequ
infect
specimen
may
undergo
culturebas
molecular
method
detect
aureusmrsa
vre
colon
base
sampl
stool
rectal
perirect
swab
use
molecular
method
culturebas
method
rectal
stool
sampl
also
use
detect
multidrugresist
gramneg
organ
extendedspectrum
enterobacteriacea
well
carbapenemaseproduc
enterobacteriacea
pseudomona
acinetobact
may
detect
multipl
site
depend
clinic
situat
includ
rectum
skin
nare
pharynx
wound
urin
trachea
patient
mechan
ventil
use
ast
without
addit
intervent
reduc
risk
transmiss
proven
effect
univers
screen
effort
pathogen
wide
studi
mrsa
consid
controversi
due
question
regard
effect
control
spread
well
cost
screen
alon
shown
effect
reduc
colon
infect
mrsa
studi
fail
show
benefit
combin
ast
isol
reduc
vre
infect
colon
howev
outbreak
vre
success
control
hospit
set
use
activ
surveil
contact
precaut
patient
isol
cohort
similarli
activ
surveil
use
follow
outbreak
mrsa
cluster
random
trial
intens
care
unit
found
univers
gown
glove
use
reduc
overal
acquisit
multidrugresist
organ
mdro
howev
small
reduct
mrsa
transmiss
note
secondari
outcom
anoth
prospect
studi
icu
patient
fail
show
differ
mrsa
transmiss
addit
concern
psychosoci
effect
isol
place
patient
observ
studi
singl
room
isol
shown
reduc
mrsa
acquisit
infect
among
hospit
patient
current
recommend
mrsa
colon
infect
patient
includ
isol
singl
room
cohort
howev
expert
call
review
current
recommend
contact
precaut
isol
mrsa
colon
view
state
concern
addit
target
decolon
strategi
ast
isol
control
spread
healthcareassoci
pathogen
extens
studi
prevent
mrsa
spread
hospit
set
patient
nasal
colon
aureu
twice
like
noncolon
patient
develop
aureu
infect
carriag
may
classifi
persist
intermitt
noncarriag
persist
colon
associ
increas
risk
infect
compar
intermitt
noncarri
carrier
high
bacteri
load
higher
risk
infect
may
like
transmit
bacteria
environ
greater
quantiti
aureu
found
nare
persist
aureu
carrier
compar
intermitt
carrier
much
research
exist
regard
efficaci
activ
surveil
cultur
combin
decolon
decreas
aureu
transmiss
infect
adult
grow
literatur
neonat
icu
intranas
antibiot
mupirocin
without
antibacteri
skin
wash
chlorhexidin
use
order
decreas
bacteri
burden
prevent
transmiss
infect
shortterm
nasal
mupirocin
demonstr
effect
erad
mrsa
nasal
carriag
success
week
treatment
efficaci
longer
durat
followup
depend
patient
profil
bodi
site
colon
nasal
mupirocin
use
highrisk
set
demonstr
effect
erad
aureu
nasal
colon
reduc
number
infect
icu
hemodialysi
surgic
longterm
care
set
studi
nearli
two
million
adult
admiss
signific
reduct
rate
mrsa
transmiss
infect
note
introduct
infect
control
bundl
includ
decolon
mrsa
carrier
isol
well
hand
hygien
program
howev
crossov
studi
univers
screen
surgic
ward
combin
target
decolon
contact
precaut
unabl
demonstr
reduct
mrsa
infect
despit
high
complianc
screen
nasal
mupirocin
decolon
nicu
infant
mrsa
colon
two
unit
high
preval
mrsa
colon
decreas
rate
mrsa
infect
howev
retrospect
studi
usa
fail
demonstr
benefit
nasal
mupirocin
use
day
colon
neonat
unit
baselin
preval
around
studi
show
nicu
infant
develop
infect
prior
detect
colon
infant
remain
nicu
becom
recolon
time
taken
togeth
data
suggest
decolon
measur
may
benefici
baselin
rate
colon
high
addit
nicu
studi
found
high
correl
colon
strain
infect
strain
confirm
high
rate
infect
occur
colon
detect
suggest
univers
rather
target
decolon
use
control
spread
mrsa
current
recommend
suggest
decolon
may
consid
highrisk
neonat
mrsa
outbreak
case
endem
mrsa
measur
fail
recent
societi
hospit
epidemiolog
associ
shea
survey
regard
practic
mrsa
identif
erad
nicu
note
perform
surveil
screen
ast
mrsa
neonat
variabl
time
sampl
site
sampl
isol
protocol
decolon
strategi
employ
recommend
mssa
less
clear
invas
mssa
infect
occur
time
frequent
invas
mrsa
infect
neonat
lead
signific
morbid
mortal
target
screen
follow
mssa
decolon
singl
nicu
reduc
incid
rate
mssaposit
clinic
cultur
mssa
infect
mupirocin
resist
among
aureu
isol
demonstr
multipl
studi
especi
associ
prolong
use
highlevel
resist
associ
decolon
failur
lowlevel
resist
may
associ
earli
recolon
therefor
longterm
use
mupirocin
question
altern
mupirocin
decolon
mupirocinresist
strain
mrsa
need
howev
longterm
studi
examin
use
mupirocin
prophylaxi
nicu
period
rate
aureu
mssa
mrsa
infect
decreas
per
patient
day
without
mupirocinresist
isol
identifi
find
consist
previou
report
low
preval
resist
among
aureu
isol
mupirocintr
neonat
use
decolon
may
effect
patient
risk
infect
short
period
time
surgic
patient
whose
risk
infect
may
less
surgic
site
close
well
icu
patient
whose
risk
may
lower
discharg
icu
import
given
patient
recolon
within
week
month
follow
decolon
thu
effect
often
shortliv
mupirocin
decolon
use
specif
reduc
risk
surgic
site
infect
ssi
associ
gramposit
organ
metaanalysi
rct
quasiexperiment
studi
includ
adult
cardiac
orthoped
surgeri
patient
mupirocin
decolon
found
significantli
protect
gramposit
ssi
specif
aureu
ssi
preoper
aureu
decolon
routin
recommend
pediatr
patient
undergo
surgeri
howev
impact
preoper
colon
risk
ssi
children
examin
mani
small
studi
risk
ssi
elev
aureuscolon
children
undergo
cardiac
surgeri
studi
adult
cardiac
surgeri
patient
howev
suggest
benefit
mupirocinbas
decolon
prevent
ssi
topic
pertain
cardiac
surgeri
discuss
chap
chlorhexidin
chg
wide
use
broadspectrum
topic
antimicrobi
agent
center
diseas
control
prevent
recommend
use
skin
cleanser
prior
insert
central
venou
cathet
cvc
children
adult
recommend
use
infant
less
month
age
due
lack
safeti
efficaci
data
popul
spite
caution
nation
survey
neonatolog
train
program
director
indic
nicu
use
chlorhexidin
cvc
site
prep
mainten
restrict
use
base
gestat
age
chronolog
age
birth
weight
risk
prematur
infant
relat
increas
potenti
chemic
burn
contact
dermat
set
underdevelop
skin
possibl
system
absorpt
chg
although
advers
event
report
despit
demonstr
blood
chg
level
chlorhexidin
bath
suggest
anoth
adjunct
decreas
colon
studi
adult
children
includ
neonat
adult
random
control
trial
demonstr
daili
chlorhexidin
bath
reduc
hai
includ
central
lineassoci
bloodstream
infect
clabsi
catheterassoci
urinari
tract
infect
cauti
ventilatorassoci
pneumonia
vap
number
studi
includ
clinic
trial
adult
howev
shown
posit
benefit
chlorhexidinecontain
product
use
part
bundl
approach
hai
prevent
pediatr
scrub
trial
daili
chlorhexidin
bath
compar
standard
bath
practic
evalu
effect
incid
bacteremia
critic
ill
children
nonstatist
signific
reduct
bacteremia
chg
group
intentiontotreat
analysi
decreas
bacteremia
per
protocol
arm
use
univers
decolon
rais
concern
possibl
chlorhexidin
resist
studi
texa
children
hospit
found
nearli
half
nosocomi
aureu
carri
one
gene
associ
chlorhexidin
toler
qacaqacb
smr
note
smrposit
isol
often
resist
methicillin
ciprofloxacin
clindamycin
well
mupirocin
resist
also
note
isol
studi
vertic
horizont
approach
infect
prevent
compar
two
studi
huang
et
al
compar
three
approach
mrsa
prevent
among
adult
icu
patient
reducemrsa
studi
vertic
approach
consist
ast
without
target
decolon
mrsa
carrier
chg
bath
intranas
mupirocin
compar
horizont
approach
involv
univers
decolon
icu
patient
regardless
mrsa
statu
univers
decolon
found
associ
largest
reduct
allcaus
bsi
mrsa
clinic
cultur
rate
anoth
group
show
improv
hand
hygien
addit
univers
chg
bath
reduc
overal
infect
rate
specif
rate
candida
cauti
acinetobact
vap
addit
high
adher
chg
bath
hand
hygien
addit
benefit
ast
isol
reduc
mdro
acquisit
rate
select
digest
decontamin
sdd
select
oral
decontamin
sod
addit
method
univers
decolon
employ
effort
reduc
colon
gramneg
organ
particularli
critic
ill
patient
method
use
polymyxin
aminoglycosid
antifung
appli
oropharynx
past
gel
sod
liquid
form
administ
per
nasogastr
orogastr
tube
sdd
pair
system
antimicrobi
usual
intraven
thirdgener
cephalosporin
two
strategi
studi
rct
examin
metaanalys
demonstr
efficaci
reduct
colon
morbid
mortal
adult
icu
patient
widespread
accept
limit
concern
select
resist
organ
univers
applic
although
longterm
followup
unit
employ
strategi
demonstr
increas
resist
organ
microbiom
studi
adult
undergo
sdd
compar
healthi
adult
reveal
dramat
shift
gastrointestin
microbiom
sdd
recipi
would
expect
well
increas
rel
abund
organ
express
antimicrobi
resist
gene
pediatr
experi
strategi
limit
singl
metaanalysi
rct
includ
children
ventilatorassoci
pneumonia
rate
lower
children
receiv
sdd
use
neonat
popul
studi
evid
periop
antimicrobi
prophylaxi
well
establish
use
antimicrobi
prior
incis
reduc
rate
ssi
reduc
concentr
potenti
pathogen
within
near
surgic
incis
basic
tenet
antimicrobi
use
prevent
ssi
includ
use
prophylaxi
elect
oper
requir
entri
hollow
viscu
involv
insert
intravascular
orthoped
prosthet
devic
implant
oper
occurr
ssi
would
pose
catastroph
risk
patient
eg
sternotomi
choic
antimicrobi
base
upon
need
bactericid
activ
expect
pathogen
specif
surgic
procedur
well
agent
known
safe
costeffect
goal
provid
bactericid
concentr
tissu
serum
time
incis
continu
throughout
entir
oper
wound
close
redos
antimicrobi
agent
may
requir
procedur
last
sever
hour
signific
blood
loss
import
risk
factor
contribut
ssi
risk
number
organ
gain
entri
wound
intraop
greater
burden
greater
risk
infect
appropri
antimicrobi
prophylaxi
administ
bacteri
burden
requir
caus
ssi
howev
foreign
bodi
present
threshold
caus
infect
may
significantli
reduc
virul
organ
also
contribut
ssi
risk
preand
periop
antisept
util
order
decreas
organ
burden
therebi
reduc
risk
ssi
preoper
bath
agent
chlorhexidin
shown
decreas
amount
endogen
flora
skin
shown
reduc
rate
ssi
pool
analys
adult
surgic
patient
certain
highrisk
popul
howev
cardiac
orthoped
surgeri
patient
preoper
chlorhexidin
bath
associ
reduc
rate
ssi
especi
due
aureu
mrsa
like
benefit
chlorhexidin
bath
influenc
type
surgic
procedur
ie
highrisk
vs
lowrisk
well
baselin
rate
ssi
given
institut
spite
controversi
use
chlorhexidin
bodi
wash
prior
surgeri
routin
sever
option
preoper
skin
antisepsi
either
chlorhexidinealcohol
povidoneiodin
activ
agent
author
cochran
review
conclud
characterist
skin
prep
agent
potenti
side
effect
cost
taken
consider
well
definit
data
show
clinic
superior
one
agent
anoth
new
cdc
guidelin
prevent
ssi
recommend
alcoholbas
skin
antisept
either
chlorhexidinealcohol
iodophoralcohol
product
surgic
site
infect
gener
aris
endogen
sourc
bacteria
present
skin
surfac
viscu
greatest
risk
occur
wound
open
addit
skin
surfac
bacteria
may
found
skin
appendag
includ
sebac
gland
hair
follicl
sweat
gland
infect
relat
exogen
sourc
occur
may
sporad
relat
outbreak
exogen
sourc
includ
contamin
oper
room
environ
surgic
instrument
equip
colon
infect
personnel
common
nosocomi
pathogen
persist
month
surfac
contribut
transmiss
risk
absenc
regular
thorough
clean
disinfect
pathogen
importantli
includ
gramposit
enterococcu
includ
vre
aureu
includ
mrsa
streptococcu
pyogen
well
gramneg
acinetobact
spp
e
coli
klebsiella
spp
p
aeruginosa
serratia
marcescen
shigella
organ
sporeform
bacteria
clostridium
difficil
surviv
month
fungi
yeast
virus
respiratori
tract
coronaviru
influenza
coxsacki
rhinoviru
surviv
rel
short
period
day
wherea
virus
gastrointestin
tract
noroviru
rotaviru
may
persist
month
surfac
room
patient
infect
colon
pathogen
may
frequent
becom
contamin
mrsa
vre
acinetobact
spp
noroviru
c
difficil
detect
environment
surfac
room
infect
colon
patient
colon
healthcar
worker
hand
transmit
other
contact
environ
like
contact
affect
patient
result
contamin
hcw
hand
presenc
environment
contamin
risk
factor
hcw
handglov
contamin
admiss
room
previous
occupi
patient
colon
infect
mrsa
vre
acinetobact
spp
c
difficil
shown
risk
factor
subsequ
develop
colon
infect
pathogen
multipl
studi
demonstr
lack
thorough
clean
contribut
persist
environment
contamin
assess
adequaci
clean
perform
use
variou
method
includ
observ
visibl
soil
culturebas
coloni
count
fluoresc
dye
atp
detect
exampl
fluoresc
dye
appli
dot
surfac
dri
clear
surfac
inadequ
wipe
area
fluoresc
expos
black
light
atp
bioluminesc
system
measur
atp
marker
presenc
residu
organ
materi
eg
human
secret
excret
food
atp
howev
indic
presenc
viabl
pathogen
absenc
rule
presenc
contamin
use
fluoresc
dye
correl
close
coloni
count
atp
bioluminesc
focus
effort
erad
pathogen
improv
clean
efficaci
may
involv
special
team
use
improv
monitor
clean
practic
marker
atp
fluoresc
dye
feedback
environment
servic
ev
staff
follow
use
enhanc
method
also
demonstr
improv
frequenc
achiev
adequ
clean
studi
acut
care
hospit
environment
surfac
clean
baselin
educ
procedur
intervent
combin
provis
object
perform
feedback
ev
staff
surfac
clean
p
addit
ensur
surfac
clean
import
select
correct
clean
product
microorgan
vari
resist
disinfect
exampl
disinfect
room
potenti
contamin
c
difficil
requir
use
hypochloritebas
solut
rather
phenol
quaternari
ammonium
compound
gener
use
gener
hospitalbas
clean
spite
enhanc
clean
method
aim
improv
clean
thorough
monitor
clean
practic
mani
surfac
remain
inadequ
clean
reason
notouch
room
disinfect
unit
decontamin
environment
surfac
object
util
either
ultraviolet
uv
light
hydrogen
peroxid
hp
vapor
develop
technolog
consid
adjunct
standard
clean
disinfect
sinc
surfac
must
physic
clean
room
must
empti
peopl
prior
use
uv
irradi
certain
wavelength
break
molecular
bond
dna
therebi
destroy
organ
shown
effect
mrsa
vre
acinetobact
baumannii
experiment
contamin
room
system
util
hp
vapor
found
effect
erad
pathogen
mrsa
mycobacterium
tuberculosi
serratia
c
difficil
spore
room
equip
method
found
effect
reduc
hai
advantag
includ
abil
substanti
reduc
c
difficil
spore
well
achiev
substanti
reduct
veget
bacteria
failur
adequ
clean
steril
equip
may
lead
transmiss
via
contamin
equip
level
disinfect
steril
consid
accept
depend
intend
use
object
categor
critic
item
come
contact
steril
tissu
semicrit
item
contact
mucou
membran
endoscop
noncrit
item
contact
skin
stethoscop
requir
steril
highlevel
disinfect
lowlevel
disinfect
respect
clean
preced
steril
disinfect
among
mani
sourc
infect
within
hospit
environ
water
remain
signific
concern
secondari
opportun
exposur
water
ubiquit
use
throughout
hospit
routin
sanit
also
air
condit
mechan
ventil
bath
well
clean
process
equip
certain
organ
special
predilect
moist
environ
includ
gramneg
bacilli
nontubercul
mycobacteria
fungi
virus
recent
review
waterborn
healthcareassoci
infect
report
describ
hospit
children
organ
primarili
respons
includ
legionella
hot
water
distribut
system
pseudomona
bottl
water
burkholderia
distil
steril
water
contamin
gener
tap
water
frequent
report
sourc
infect
contamin
sink
shower
bathtub
legionella
primari
caus
hai
among
patient
includ
review
predomin
organ
caus
outbreak
legionella
outbreak
report
prematur
neonat
associ
humidif
tray
incub
term
neonat
associ
cold
mist
humidifi
environment
control
measur
gener
insuffici
erad
requir
use
multistep
control
plan
includ
educ
use
steril
water
immunocompromis
patient
use
period
clean
shower
tub
sink
use
disinfect
systemsfilt
tap
shower
head
team
specialist
area
infect
control
includ
engin
requir
erad
contamin
water
systemsuppli
occur
endogen
exogen
microb
constant
threat
hospit
patient
effort
decreas
endogen
pathogen
via
decolon
skin
antisepsi
decreas
risk
infect
set
control
spread
potenti
pathogen
environ
requir
meticul
attent
clean
disinfect
practic
well
hand
hygien
